Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By
Real members of MyParkinsonsTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

So, nobody has mentioned anything about the new drug, Juvmo that was approved by the FDA a couple of days ago.

A MyParkinsonsTeam Member asked a question 💭
Sun City Center, FL

It’s supposed to target the D1 and D5 dopamine receptors. It’s a single pill once daily. You’re supposed to take it along with your Carbidopa/Levodopa pill. It should be available this month but I’m not sure when the insurance companies will decide how much they will cover on this drug. This is the first new drug to have come out in decades.

October 1
 · 
Reactions

Answer Summary

Members shared excitement and cautious curiosity about Juvmo, a newly FDA-approved drug targeting dopamine receptors that is taken alongside... Read more

Members shared excitement and cautious curiosity about Juvmo, a newly FDA-approved drug targeting dopamine receptors that is taken alongside Carbidopa/Levodopa for Parkinson's disease. Several members noted promising early experiences, including one trial participant who reported real improvement, while others raised concerns about side effects, gait limitations, and the steep list price of $4,900 per month. A recurring theme was the hope this drug brings balanced with the frustrating uncertainty around insurance coverage, with Medicare Part D expected to take up to 180 days to assign a cost tier.

A MyParkinsonsTeam Member

Medicare Part D has about 90 days to review the new drug and up to 180 days to classify it within a tier, and then they can see what they will charge for the drug. So, it’ll be at least 6 months or more before we know. If you’re younger than 65 years old, it will also take some time to determine a cost.

October 8
A MyParkinsonsTeam Member

I take the Sinemet now, so taking this new drug would be an addition to the Carbidopa/Llevodopa pill. So, you’re not changing anything. My issue is what the cost would be with my Medicare Drug Plan.

October 1
A MyParkinsonsTeam Member

This is in response to the MyParkinsonsTeam comment about the new drug, JUVMO. AbbVie announced on September 28th that the FDA had approved the use of JUVMO based on Stage 3 clinical trial data. It was even applauded by the Michael J. Fox Foundation as a breakthrough in the fight against Parkinson’s Disease. So, I don’t know how you can state that there is no verified information that this drug was approved by the FDA?

My Neurologist actually confirmed it when I had an appointment with her on 9/28.

October 1
A MyParkinsonsTeam Member

@A MyParkinsonsTeam Member, I saw the announcement, but I have not researched it. Until I do, I will remain skeptical.

October 1
A MyParkinsonsTeam Member

Thanks to all of you who have sent me hugs or questions I have not answered. But I have my hands full with taking care of everything since my hub got P.D. probably have posted this before.. But want you to know I love all the hugs I get as they help me a lot and appreciate you all very much. Hope you all had a great day. God Bless you all. Colleen❤️🙏🤗🤗😊

October 9

Related Questions

View All

Has anyone used stem cells?

A MyParkinsonsTeam Member asked a question 💭
Asheville, NC
April 26, 2023

Has anyone been reading up on the two new drug therapies for PD?

A MyParkinsonsTeam Member asked a question 💭
Tampa, FL
October 23, 2017

3 Layers of COVID-19 Protection: New Vaccines, Prevention Drug, and Tests
Get the most out of MyParkinsonsTeam by tailoring your own team!
The History of Parkinson’s Disease: Key Milestones
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In